This educational session will discuss advances in how relapsed/refractory CLL patients and those who fail a treatment are treated today. What therapies are used for subsequent treatments and what promising new developments may fulfil unmet treatment needs?
During this session we will explore:
- Fixed term and continuous treatments
- Solutions in the multiple-relapsed-refractory group
- Overcoming challenges for the clinician and the patient
- New technologies
- Treatment sequencing
By registering for this webinar you will automatically be enrolled in receiving our email communications about our services.